Position in NTRA
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$454,135
+$105,553 QoQ
Shares Held
1,673
-4.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#554
of 844 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Essex Financial Services, Inc. holds $8,380,568 across 10 Diagnostics & Research names. NTRA ranks #6 (5.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
7,677 | $3,848,940 | |
| 2 | DHR |
Danaher Corp /De/
|
5,333 | $1,015,829 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
1,565 | $823,878 | |
| 4 | LH |
Labcorp Holdings Inc.
|
2,248 | $629,440 | |
| 5 | DGX |
Quest Diagnostics Inc
|
2,653 | $562,303 | |
| 6 | NTRA |
Natera, Inc.
This page
|
1,673 | $454,135 | |
| 7 | ILMN |
Illumina, Inc.
|
1,716 | $301,724 | |
| 8 | WAT |
Waters Corp /De/
|
732 | $274,529 |
All Filings in NTRA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $454,135 | 1,673 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $348,582 | 1,743 | Shares | Defined | 2026-04-24 | |
| 2025-12-31 | $396,554 | 1,731 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $209,904 | 1,304 | Shares | Defined | 2025-11-07 | |
| No filing history on record for this holder in this stock. | ||||||